Cancer Antigen Controls – CA 125, CA 72-4, CA 19-9, CA 15-3
Cancer Antigens CA 125, CA 72-4, CA 19-9, CA 15-3 – Research Grade Tumor Markers
Golden West BioSolutions offers a comprehensive panel of cancer antigens, including CA 125, CA 72-4, CA 19-9, and CA 15-3, widely used as tumor markers in oncology research and in vitro diagnostic (IVD) development. These antigens are derived from human cell culture supernatants, fluids, ascites, and tumors, and are processed under rigorous quality standards for consistency and reliability.
Each product is tested non-reactive for HIV, HCV, HBV, and Syphilis using FDA-approved methods and is supplied as a filtered liquid with sodium azide in phosphate-buffered saline. These tumor markers are essential tools for tracking disease progression, evaluating therapeutic response, and validating assay sensitivity in cancers such as ovarian, breast, pancreatic, and gastrointestinal tumors.
Key Features
CA 125 – Ovarian cancer-associated marker (Cat. #: A1040) - Cancer Antigen 125 Spec Sheet
CA 72-4 – Marker for gastrointestinal and gastric cancers (Cat. #: A1035) - Cancer Antigen 72-4 Spec Sheet
CA 19-9 – Pancreatic and GI tumor-associated antigen (Cat. #: A1020) - Cancer Antigen 19-9 Spec Sheet
CA 15-3 – Breast cancer marker (Cat. #: A1015) - Cancer Antigen 15-3 Spec Sheet
Sourced from native biological matrices (cell culture supernatant, ascites, fluids)
0.2 µm filtered and formulated in PBS, with sodium azide preservative
Stored at –20°C or refrigerated depending on the product
Tested non-reactive for major bloodborne pathogens
For research use or manufacturing of non-injectable products only
Applications
Development and calibration of immunoassays (ELISA, CLIA, LFA)
Oncology biomarker research and tumor monitoring studies
Quality control materials for diagnostic kit production
Detection of recurrence and therapy response tracking in cancer patients
Multiplex cancer antigen panel studies and comparative assay validation
Cancer Antigens CA 125, CA 72-4, CA 19-9, CA 15-3 – Research Grade Tumor Markers
Golden West BioSolutions offers a comprehensive panel of cancer antigens, including CA 125, CA 72-4, CA 19-9, and CA 15-3, widely used as tumor markers in oncology research and in vitro diagnostic (IVD) development. These antigens are derived from human cell culture supernatants, fluids, ascites, and tumors, and are processed under rigorous quality standards for consistency and reliability.
Each product is tested non-reactive for HIV, HCV, HBV, and Syphilis using FDA-approved methods and is supplied as a filtered liquid with sodium azide in phosphate-buffered saline. These tumor markers are essential tools for tracking disease progression, evaluating therapeutic response, and validating assay sensitivity in cancers such as ovarian, breast, pancreatic, and gastrointestinal tumors.
Key Features
CA 125 – Ovarian cancer-associated marker (Cat. #: A1040) - Cancer Antigen 125 Spec Sheet
CA 72-4 – Marker for gastrointestinal and gastric cancers (Cat. #: A1035) - Cancer Antigen 72-4 Spec Sheet
CA 19-9 – Pancreatic and GI tumor-associated antigen (Cat. #: A1020) - Cancer Antigen 19-9 Spec Sheet
CA 15-3 – Breast cancer marker (Cat. #: A1015) - Cancer Antigen 15-3 Spec Sheet
Sourced from native biological matrices (cell culture supernatant, ascites, fluids)
0.2 µm filtered and formulated in PBS, with sodium azide preservative
Stored at –20°C or refrigerated depending on the product
Tested non-reactive for major bloodborne pathogens
For research use or manufacturing of non-injectable products only
Applications
Development and calibration of immunoassays (ELISA, CLIA, LFA)
Oncology biomarker research and tumor monitoring studies
Quality control materials for diagnostic kit production
Detection of recurrence and therapy response tracking in cancer patients
Multiplex cancer antigen panel studies and comparative assay validation
Cancer Antigens CA 125, CA 72-4, CA 19-9, CA 15-3 – Research Grade Tumor Markers
Golden West BioSolutions offers a comprehensive panel of cancer antigens, including CA 125, CA 72-4, CA 19-9, and CA 15-3, widely used as tumor markers in oncology research and in vitro diagnostic (IVD) development. These antigens are derived from human cell culture supernatants, fluids, ascites, and tumors, and are processed under rigorous quality standards for consistency and reliability.
Each product is tested non-reactive for HIV, HCV, HBV, and Syphilis using FDA-approved methods and is supplied as a filtered liquid with sodium azide in phosphate-buffered saline. These tumor markers are essential tools for tracking disease progression, evaluating therapeutic response, and validating assay sensitivity in cancers such as ovarian, breast, pancreatic, and gastrointestinal tumors.
Key Features
CA 125 – Ovarian cancer-associated marker (Cat. #: A1040) - Cancer Antigen 125 Spec Sheet
CA 72-4 – Marker for gastrointestinal and gastric cancers (Cat. #: A1035) - Cancer Antigen 72-4 Spec Sheet
CA 19-9 – Pancreatic and GI tumor-associated antigen (Cat. #: A1020) - Cancer Antigen 19-9 Spec Sheet
CA 15-3 – Breast cancer marker (Cat. #: A1015) - Cancer Antigen 15-3 Spec Sheet
Sourced from native biological matrices (cell culture supernatant, ascites, fluids)
0.2 µm filtered and formulated in PBS, with sodium azide preservative
Stored at –20°C or refrigerated depending on the product
Tested non-reactive for major bloodborne pathogens
For research use or manufacturing of non-injectable products only
Applications
Development and calibration of immunoassays (ELISA, CLIA, LFA)
Oncology biomarker research and tumor monitoring studies
Quality control materials for diagnostic kit production
Detection of recurrence and therapy response tracking in cancer patients
Multiplex cancer antigen panel studies and comparative assay validation
Testing:
The Cell Line Supernatant was tested and found non-reactive for HIV 1/2, HBsAg, HCV, HIV-1 (NAT) and HCV (NAT) by current FDA methods. Please note that the samples tested were Cell Culture Supernatants, not serum and not appropriate for use in these assays.
Intended Use and Customer Responsibility
Golden West BioSolutions, LLC products are specifically designed for research and the manufacturing of non-injectable products. It is the customer's responsibility to handle these products safely and responsibly. Golden West BioSolutions, LLC is not liable for any injuries stemming from the use or handling of its products. All disposal procedures must align with federal and state regulations.
Quality Assurance Disclaimer
Golden West BioSolutions, LLC does not warrant the performance of their products in specific applications. Customers are responsible for determining the suitability and qualification of Golden West BioSolution products for their intended use. Given the natural variation in biological materials, Golden West BioSolutions, LLC also recommends consideration of lot-to-lot evaluation.